Information Links
Guidelines - Mental health
Quick-reference summaries of key national treatment guidance for mental health related conditions.
MIMS summaries
NICE technology appraisals
Decisions by the National Institute for Health and Care Excellence on NHS access to treatments for mental health disorders.
-
Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease (TA217)
-
Vortioxetine for Treating Major Depressive Episodes (TA367)
-
Aripiprazole for Treating Moderate to Severe Manic Episodes in Adolescents with Bipolar I Disorder (TA292)
-
Aripiprazole for the Treatment of Schizophrenia in People Aged 15 to 17 Years (TA213)
-
Insomnia: Zaleplon, Zolpidem and Zopiclone (NICE)
MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.